Photodynamic therapy for the treatment of complex anal fistula

Tech Coloproctol. 2017 Feb;21(2):149-153. doi: 10.1007/s10151-016-1571-y. Epub 2017 Jan 20.

Abstract

Background: Photodynamic therapy (PDT) is a new procedure for the treatment of anal fistula. This preliminary study was designed to investigate the safety and effectiveness of this new technique in the treatment of anal fistula.

Methods: Ten patients were treated with PDT. Intralesional 5-aminolevulinic acid (ALA) 2% was directly injected into the fistula. The internal and external orifices were closed. After an incubation period of 2 h, the fistula was irradiated using an optical fibre connected to a red laser (MULTIDIODE 630 PDT, INTERmedic, Spain) operating at 1 W/cm for 3 min (180 Joules). Patient demographics, operation notes and complications were recorded.

Results: There were no complications. The average length of patient follow-up was 14.9 months (range 12-20 months). We could observe primary healing in eight patients (80%). Two patients (20%) showed persistence of suppuration after the operation. No patient reported incontinence postoperatively.

Conclusions: PDT is a potential sphincter-saving procedure that is safe, simple and minimally invasive and has a high success rate.

Keywords: Aminolevulinic acid; Anal fistula; Photodynamic therapy.

Publication types

  • Evaluation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aminolevulinic Acid / administration & dosage*
  • Anti-Infective Agents / administration & dosage
  • Antibiotic Prophylaxis / methods
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Injections
  • Laser Therapy / methods*
  • Male
  • Metronidazole / administration & dosage
  • Middle Aged
  • Photochemotherapy / methods*
  • Photosensitizing Agents / administration & dosage*
  • Rectal Fistula / drug therapy*
  • Tobramycin / administration & dosage
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Infective Agents
  • Photosensitizing Agents
  • Metronidazole
  • Aminolevulinic Acid
  • Tobramycin